Arkolith/Insider Trading/CEMI/Form 4

Acheson David

DirectorCHEMBIO DIAGNOSTICS, INC. (CEMI) · full profile →Form 4 · filed May 1, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
3 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 26, 2023Tender(U)10K$0.45$4K0
Dec 17, 2022Option exercise(M)5K——10K
Dec 17, 2021Option exercise(M)5K——5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2023Disposed to issuer(D)41K——0
Apr 27, 2023Disposed to issuer(D)36K——0
Apr 27, 2023Disposed to issuer(D)24K——0
Dec 17, 2022Option exercise(M)5K—$05K
Dec 17, 2021Option exercise(M)5K—$010K

Transaction Codes

U
See SEC Form 4 code table
M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-23-022236) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML